End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 USD | -9.38% | -9.38% | -27.62% |
06-14 | Zura Bio Presents Data for the Tibulizumab (Zb-106) Program At Eular 2024 | CI |
06-06 | Zura Bio Limited Announces Formation of a Scientific Advisory Board | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.62% | 216M | |
+15.85% | 122B | |
+18.91% | 113B | |
+7.19% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-15.80% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Guggenheim Initiates Zura Bio at Buy With $20 Price Target